Pages that link to "Q36896204"

The following pages link to Somatic Mosaic Mutations in PPM1D and TP53 in the Blood of Women With Ovarian Carcinoma. (Q36896204):

Displaying 29 items.

• Therapy-related myeloid neoplasms: does knowing the origin help to guide treatment? (Q30240431) (← links)
• WIP1 phosphatase as pharmacological target in cancer therapy. (Q33720757) (← links)
• The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia (Q33796552) (← links)
• Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma. (Q34548829) (← links)
• Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly (Q34556382) (← links)
• Germline, hematopoietic, mosaic, and somatic variation: interplay between inherited and acquired genetic alterations in disease assessment (Q37311095) (← links)
• Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel (Q37624593) (← links)
• Therapy-related myeloid neoplasms: when genetics and environment collide (Q38611096) (← links)
• Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes (Q38627087) (← links)
• Truncating and missense PPM1D mutations in early-onset and/or familial/hereditary prostate cancer patients. (Q39613092) (← links)
• De Novo Truncating Mutations in the Last and Penultimate Exons of PPM1D Cause an Intellectual Disability Syndrome (Q40063882) (← links)
• Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation (Q42158416) (← links)
• Somatic TP53 variants frequently confound germ-line testing results (Q46051827) (← links)
• Mosaic mutations in blood DNA sequence are associated with solid tumor cancers (Q47157222) (← links)
• Clonal Hematopoiesis and Evolution to Hematopoietic Malignancies (Q50209900) (← links)
• Medullary thyroid cancer, leukemia, mesothelioma and meningioma associated with germline APC and RASAL1 variants: a new syndrome? (Q52666449) (← links)
• Identification of Clonal Hematopoiesis Mutations in Solid Tumor Patients Undergoing Unpaired Next-Generation Sequencing Assays (Q57785080) (← links)
• PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy (Q58547326) (← links)
• Clonal Hematopoiesis and Its Impact on Cardiovascular Disease (Q63976992) (← links)
• Concise Review: Age-Related Clonal Hematopoiesis: Stem Cells Tempting the Devil (Q89040974) (← links)
• PPM1D-truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cells (Q89320681) (← links)
• Li-Fraumeni syndrome: not a straightforward diagnosis anymore-the interpretation of pathogenic variants of low allele frequency and the differences between germline PVs, mosaicism, and clonal hematopoiesis (Q90166337) (← links)
• Are liquid biopsies ready for primetime? (Q90733408) (← links)
• Cancer genetics, precision prevention and a call to action (Q91211233) (← links)
• Diagnosis of Li-Fraumeni Syndrome: Differentiating TP53 germline mutations from clonal hematopoiesis: Results of the observational AGO-TR1 trial (Q91450129) (← links)
• Next-generation sequencing with comprehensive bioinformatics analysis facilitates somatic mosaic APC gene mutation detection in patients with familial adenomatous polyposis (Q91590370) (← links)
• Detectible mosaic truncating PPM1D mutations, age and breast cancer risk (Q92237320) (← links)
• Identifying sequence variants contributing to hereditary breast and ovarian cancer in BRCA1 and BRCA2 negative breast and ovarian cancer patients (Q92287170) (← links)
• Somatic mosaic truncating mutations of PPM1D in blood can result from expansion of a mutant clone under selective pressure of chemotherapy (Q93046091) (← links)